Prematurity is related to high placental cortisol in preeclampsia

Pediatric Research

Volumn 65, Issue 2, 2009, Pages 198-202

  Aufdenblatten, Myriam ^a   Baumann, Marc ^a   Raio, Luigi ^a   Dick, Bernhard ^a   Frey, Brigitte M ^a   Schneider, Henning ^a   Surbek, Daniel ^a   Hocher, Berthold ^a,b   Mohaupt, Markus G ^a,c  

^a UNIVERSITY OF BERN   (Switzerland)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 2; ESTRADIOL; HYDROCORTISONE; PREGNANEDIOL;

ADULT; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; CORRELATION ANALYSIS; ENZYME ACTIVITY; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; INTRAUTERINE GROWTH RETARDATION; PLACENTA; PREECLAMPSIA; PREMATURITY; PRIORITY JOURNAL; RISK FACTOR;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ADULT; BIRTH WEIGHT; CASE-CONTROL STUDIES; ESTRADIOL; FEMALE; GESTATIONAL AGE; HUMANS; HYDROCORTISONE; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; ODDS RATIO; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREMATURE BIRTH; PROGESTERONE; RISK ASSESSMENT; RISK FACTORS; UP-REGULATION;

EID: 60449115911     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e31818d6c24     Document Type: Article

References (43)

1. Seckl JR, Holmes MC 2007 Mechanisms of disease: glucocorticoids, their placental metabolism and fetal 'programming' of adult pathophysiology. Nat Clin Pract Endocrinol Metab 3:479-488
2. Schoof E, Girstl M, Frobenius W, Kirschbaum M, Repp R, Knerr I, Rascher W, Dotsch J 2001 Course of placental 11 β-hydroxysteroid dehydrogenase type 2 and 15-hydroxyprostaglandin dehydrogenase mRNA expression during human gestation. Eur J Endocrinol 145:187-192
3. Hardy DB, Yang K 2002 The expression of 11β-hydroxysteroid dehydrogenase type 2 is induced during trophoblast differentiation: effects of hypoxia. J Clin Endocrinol Metab 87:3696-3701
4. Odermatt A, Arnold P, Frey FJ 2001 The intracellular localization of the mineralocorticoid receptor is regulated by 11β-hydroxysteroid dehydrogenase type 2. J Biol Chem 276:28484-28492
5. French NP, Hagan R, Evans SF, Godfrey M, Newnham JP 1999 Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol 180:114-121
6. Reinisch JM, Simon NG, Karow WG, Gandelman R 1978 Prenatal exposure to prednisone in humans and animals retards intrauterine growth. Science 202:436-438
7. Heiniger CD, Kostadinova RM, Rochat MK, Serra A, Ferrari P, Dick B, Frey BM, Frey FJ 2003 Hypoxia causes down-regulation of 11β-hydroxysteroid dehydrogenase type 2 by induction of Egr-1. FASEB J 17:917-919
8. Lanz B, Kadereit B, Ernst S, Shojaati K, Causevic M, Frey BM, Frey FJ, Mohaupt MG 2003 Angiotensin II regulates 11β-hydroxysteroid dehydrogenase type 2 via AT2 receptors. Kidney Int 64:970-977
9. Lanz CB, Causevic M, Heiniger C, Frey FJ, Frey BM, Mohaupt MG 2001 Fluid shear stress reduces 11β-hydroxysteroid dehydrogenase type 2. Hypertension 37:160-169
10. 2+ and cAMP pathways. Am J Physiol Endocrinol Metab 290:E282-E288
11. Kajantie E, Dunkel L, Turpeinen U, Stenman UH, Wood PJ, Nuutila M, Andersson S 2003 Placental 11β-hydroxysteroid dehydrogenase-2 and fetal cortisol/cortisone shuttle in small preterm infants. J Clin Endocrinol Metab 88:493-500
12. Dy J, Guan H, Sampath-Kumar R, Richardson BS, Yang K 2008 Placental 11β-hydroxysteroid dehydrogenase type 2 is reduced in pregnancies complicated with idiopathic intrauterine growth restriction: evidence that this is associated with an attenuated ratio of cortisone to cortisol in the umbilical artery. Placenta 29:193-200
13. McCalla CO, Nacharaju VL, Muneyyirci-Delale O, Glasgow S, Feldman JG 1998 Placental 11β-hydroxysteroid dehydrogenase activity in normotensive and preeclamptic pregnancies. Steroids 63:511-515
14. Lee MJ, Wang Z, Yee H, Ma Y, Swenson N, Yang L, Kadner SS, Baergen RN, Logan SK, Garabedian MJ, Guller S 2005 Expression and regulation of glucocorticoid receptor in human placental villous fibroblasts. Endocrinology 146:4619-4626
15. Driver PM, Rauz S, Walker EA, Hewison M, Kilby MD, Stewart PM 2003 Characterization of human trophoblasts as a mineralocorticoid target tissue. Mol Hum Reprod 9:793-798
16. Seckl JR, Cleasby M, Nyirenda MJ 2000 Glucocorticoids, 11β-hydroxysteroid dehydrogenase, and fetal programming. Kidney Int 57:1412-1417
17. Higgins JR, de Swiet M 2001 Blood-pressure measurement and classification in pregnancy. Lancet 357:131-135
18. Voigt M, Schneider KT, Jahrig K 1996 [Analysis of 1992 birth sample in Germany. 1: new percentile values of the body weight of newborn infants]. Geburtshilfe Frauenheilkd 56:550-558
19. Beinder E, Mohaupt MG, Schlembach D, Fischer T, Sterzel RB, Lang N, Baylis C 1999 Nitric oxide synthase activity and Doppler parameters in the fetoplacental and uteroplacental circulation in preeclampsia. Hypertens Pregnancy 18:115-127
20. Shackleton CH 1993 Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research. J Steroid Biochem Mol Biol 45:127-140
21. Alfaidy N, Gupta S, DeMarco C, Caniggia I, Challis JR 2002 Oxygen regulation of placental 11β-hydroxysteroid dehydrogenase 2: physiological and pathological implications. J Clin Endocrinol Metab 87:4797-4805
22. Gunter HH, Berger L, Messner U, Niesert S 1995 [Estriol and human placental lactogen as risk indicators in pregnancies of diabetic and hypertensive patients]. Z Geburtshilfe Neonatol 199:142-147
23. Oszczygiel VA 1975 [Progesterone and pregnandiol levels in the pripheral blood and urinary pregnandiol level in pregnant women before and after delivery]. Zentralbl Gynakol 97:301-306
24. Best R, Walker BR 1997 Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11β-hydroxysteroid dehydrogenase in vivo. Clin Endocrinol (Oxf) 47:231-236
25. Kitanaka S, Tanae A, Hibi I 1996 Apparent mineralocorticoid excess due to 11 βhydroxysteroid dehydrogenase deficiency: a possible cause of intrauterine growth retardation. Clin Endocrinol (Oxf) 44:353-359
26. Stewart PM, Rogerson FM, Mason JI 1995 Type 2 11β-hydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal adrenal steroidogenesis. J Clin Endocrinol Metab 80:885-890
27. Symonds ME, Stephenson T, Gardner DS, Budge H 2007 Long-term effects of nutritional programming of the embryo and fetus: mechanisms and critical windows. Reprod Fertil Dev 19:53-63
28. Rich-Edwards JW, Kleinman K, Michels KB, Stampfer MJ, Manson JE, Rexrode KM, Hibert EN, Willett WC 2005 Longitudinal study of birth weight and adult body mass index in predicting risk of coronary heart disease and stroke in women. BMJ 330:1115
29. Curhan GC, Chertow GM, Willett WC, Spiegelman D, Colditz GA, Manson JE, Speizer FE, Stampfer MJ 1996 Birth weight and adult hypertension and obesity in women. Circulation 94:1310-1315
30. Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS 1993 Fetal nutrition and cardiovascular disease in adult life. Lancet 341:938-941
31. Benediktsson R, Calder AA, Edwards CR, Seckl JR 1997 Placental 11β-hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure. Clin Endocrinol (Oxf) 46:161-166
32. Goland RS, Jozak S, Warren WB, Conwell IM, Stark RI, Tropper PJ 1993 Elevated levels of umbilical cord plasma corticotropin-releasing hormone in growth-retarded fetuses. J Clin Endocrinol Metab 77:1174-1179
33. Goland RS, Tropper PJ, Warren WB, Stark RI, Jozak SM, Conwell IM 1995 Concentrations of corticotrophin-releasing hormone in the umbilical-cord blood of pregnancies complicated by pre-eclampsia. Reprod Fertil Dev 7:1227-1230
34. Walker BR, Williamson PM, Brown MA, Honour JW, Edwards CR, Whitworth JA 1995 11β-Hydroxysteroid dehydrogenase and its inhibitors in hypertensive pregnancy. Hypertension 25:626-630
35. Strinic T, Bukovic D, Radic A, Sumilin L, Hauptman D, Sovic T 2005 Comparison of fetal plasma cortisol level between eutrophic and hypotrophic newborns. Coll Antropol 29:739-741
36. Procianoy RS, Cecin SK 1986 Umbilical cord dehydroepiandrosterone sulfate and cortisol levels in preterm infants born to pre-eclamptic mothers. Acta Paediatr Scand 75:279-282
37. Matthews SG, Yang K, Challis JR 1995 Changes in glucocorticoid receptor mRNA in the developing ovine pituitary and the effects of exogenous cortisol. J Endocrinol 144:483-490
38. Kadereit B, Fustier P, Shojaati K, Frey BM, Frey FJ, Mohaupt MG 2005 Extracellular ATP determines 11β-hydroxysteroid dehydrogenase type 2 activity via purinergic receptors. J Am Soc Nephrol 16:3507-3516
39. Heiniger CD, Rochat MK, Frey FJ, Frey BM 2001 TNF-α; enhances intracellular glucocorticoid availability. FEBS Lett 507:351-356
40. Homan A, Guan H, Hardy DB, Gratton RJ, Yang K 2006 Hypoxia blocks 11;β-hydroxysteroid dehydrogenase type 2 induction in human trophoblast cells during differentiation by a time-dependent mechanism that involves both translation and transcription. Placenta 27:832-840
41. Struwe E, Berzl GM, Schild RL, Beckmann MW, Dorr HG, Rascher W, Dotsch J 2007 Simultaneously reduced gene expression of cortisol-activating and cortisol-inactivating enzymes in placentas of small-for-gestational-age neonates. Am J Obstet Gynecol 197:43.e1-e6
42. Salas SP, Marshall G, Gutierrez BL, Rosso P 2006 Time course of maternal plasma volume and hormonal changes in women with preeclampsia or fetal growth restriction. Hypertension 47:203-208
43. Glass IA, Lam RC, Chang T, Roitman E, Shapiro LJ, Shackleton CH 1998 Steroid sulphatase deficiency is the major cause of extremely low oestriol production at mid-pregnancy: a urinary steroid assay for the discrimination of steroid sulphatase deficiency from other causes. Prenat Diagn 18:789-800